Helicobacter pylori (H. pylori), which infects about 50% of the global population, has been
recognized as a main risk factor of multiple gastric pathologies, especially non-cardiac
gastric cancer. Strongly evidence supports that H. pylori eradication is an effective
approach to reduce the incidence of those pathologies.